Search | TVST | ARVO Journals

Showing 1 – 20 of 44

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Leber Hereditary Optic Neuropathy Gene Therapy: Longitudinal Relationships Among Visual Function and Anatomical Measures

Byron L Lam; Vittorio Porciatti; Janet L Davis; D. Diane Zheng; Elizabeth Vanner; Eleonore J. Savatovsky; Diego Alba

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1957.

ARVO Annual Meeting Abstract June 2022

Findings on visual photosensitivity in two phase 1/2 clinical trials of subretinal gene therapy with AGTC-401 and AGTC-402 for CNGB3 and CNGA3 achromatopsia

Rachel M Huckfeldt; Jason Comander; Mark E Pennesi; Paul Yang; Andreas Lauer; Robert Sisk; Edward Averbukh; Eyal Banin; Ninel Z Gregori; Janet L Davis; Byron L Lam; Christine Nichols Kay; Jessica Ijams Wolfing Morgan; Joseph Carroll; Bright Senyo Ashimatey; Matthew Feinsod

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):450.

ARVO Annual Meeting Abstract June 2022

Leber Hereditary Optic Neuropathy Gene Therapy: Adverse Events and Visual Acuity Results of all Patient Groups

Byron L Lam; William J Feuer; Janet L Davis; Vittorio Porciatti; Hong Yu; Robert Levy; Elizabeth Vanner; John Guy

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1576 – A0365.

ARVO Annual Meeting Abstract June 2022

Interim Safety Results in Two Phase 1/2 Open-label, Dose-escalation Clinical Trials of Subretinal Gene Therapy with AGTC-401 (rAAV2tYF-PR1.7-hCNGB3) and AGTC-402 (rAAV2tYF-PR1.7-hCNGA3) in Subjects with Achromatopsia (ACHM)

Alessandro Iannaccone; Mark E Pennesi; Paul Yang; Andreas Lauer; Robert Sisk; Ninel Z Gregori; Janet L Davis; Byron L Lam; Christine Nichols Kay; Mauro Goldbaum; Bright Senyo Ashimatey; Feng Zhu; Matthew Feinsod; Lejla Vajzovic

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2829 – A0345.

Articles March 2022

The Relationship Between Stage of Leber's Hereditary Optic Neuropathy and Pattern Electroretinogram Latency

PDF

Vittorio Porciatti; Diego E. Alba; William J. Feuer; Janet Davis; John Guy; Byron L. Lam
TAGS: electroretinography, optic atrophy, hereditary, leber, steady state, eye
Trans. Vis. Sci. Tech.. 2022; 11(3):31. https://doi.org/10.1167/tvst.11.3.31

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Progressive shortening of Steady-State Pattern ERG latency with increased LHON severity

Vittorio Porciatti; Diego Alba; William J Feuer; Janet L Davis; Byron L Lam

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2679.

ARVO Annual Meeting Abstract June 2021

Twelve-month Findings from Two Phase 1/2 Clinical Studies of Subretinal Gene Therapy Drugs for Achromatopsia

Mark E Pennesi; Paul Yang; Andreas Lauer; Robert A Sisk; Jason M Comander; Rachel M. Huckfeldt; Edward Averbuhk; Eyal Banin; Ninel Gregori; Janet L Davis; Byron L Lam; Christine Kay; Erin Leone; Deanine Halliman; Nnenna Ihekoromadu; Matthew Feinsod

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3321.

ARVO Annual Meeting Abstract June 2020

A Novel Method to Detect and Monitor Retinal Vasculitis Using Swept Source OCT Angiography

Jila Noorikolouri; Yingying Shi; Jin Yang; Thomas Albini; Giovanni Gregori; Philip J Rosenfeld; Janet L Davis

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4333.

ARVO Annual Meeting Abstract July 2019

Preliminary results in 18 patients undergoing retinal gene therapy for X-linked retinitis pigmentosa with codon-optimized AAV8-RPGR

Robert E MacLaren; Janet L Davis; Ninel Gregori; Jasmina Cehajic-Kapetanovic; Byron L Lam; Andrew Lotery; Cristina Martinez-Fernandez dela Camara; Anika Nanda; Anna Paola Salvetti; Paulo Stanga; Kanmin Xue

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1329.

ARVO Annual Meeting Abstract July 2019

Gene Therapy for Leber Hereditary Optic NeuropathY An update of Where We Stand (Clinicaltrials.gov number: NCT02161380)

John Guy; William Feuer; Janet L Davis; Vittorio Porciatti; Philip Gonzalez; Rajeshwari D Koilkonda; Huijun Yuan; Byron L Lam

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3602.

ARVO Annual Meeting Abstract July 2019

Prevalence of Retinal Gene Mutations in Patients Undergoing Evaluation for Autoimmune Retinopathy with Antiretinal Antibodies

Jila Noorikolouri; Janet L Davis

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6674.

ARVO Annual Meeting Abstract July 2019

Polymerase Chain Reaction for the Diagnosis of Chorioretinal Infections: Comparative Study of Testing in a Single Institution

Janet L Davis; Sulaiman Alhumaid

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):823.

ARVO Annual Meeting Abstract July 2019

Polymerase Chain Reaction in the Diagnosis of Toxoplasma gondii Chorioretinitis

JOHN W HINKLE; Sulaiman Alhumaid; Darlene Miller; Janet L Davis; Thomas A Albini

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):824.

ARVO Annual Meeting Abstract July 2019

OCT-Angiography in Vogt Koyanagi Harada Syndrome: A Comparative Cross Sectional Imaging Analysis

Justin Yamanuha; Janet L Davis; Jila Noorikolouri

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4553.

ARVO Annual Meeting Abstract July 2018

Pars plana vitrectomy for the treatment of uveitis

Christopher Ryan Henry; Matthias Becker; Yang Yongsheng; Janet L. Davis

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4199.

ARVO Annual Meeting Abstract July 2018

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Elizabeth A Sugar; Janet A Holbrook; Alyce E Burke; Glenn J Jaffe; Albert T Vitale; Janet L. Davis; Douglas A Jabs

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):417.

ARVO Annual Meeting Abstract June 2017

Choroideremia Gene Therapy Phase II Clinical Trial: 6-Month Results

Byron L Lam; Jennifer Verriotto; Ninel Gregori; Janet L Davis

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3386.

ARVO Annual Meeting Abstract June 2017

Neutralizing Antibodies Against Adeno-associated virus (AAV)2 Capsids in LHON Gene Therapy Clinical Trial Patients: An Update

Rajeshwari D Koilkonda; William J Feuer; Joyce Schiffman; Janet L Davis; Vittorio Porciatti; Phillip Gonzalez; Byron L Lam; John Guy

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3861.

ARVO Annual Meeting Abstract June 2017

Gene Therapy for LHON Suppresses Neurodegeneration

John Guy; Rajeshwari D Koilkonda; William J Feuer; Janet L Davis; Vittorio Porciatti; Phillip Gonzalez; Huijan Yuan; Byron L Lam

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4492.

ARVO Annual Meeting Abstract September 2016

Feasibility of a Self-administered, Computer Guided, Visual Perception Training Software for the Argus II Retinal Prosthesis.

Alex Gonzalez; Carmen Torres; Mariela C Aguilar; Cornelis Rowaan; Byron L Lam; Ninel Gregori; Janet L Davis; Jean-Marie A Parel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):635.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Leber Hereditary Optic Neuropathy Gene Therapy: Longitudinal Relationships Among Visual Function and Anatomical Measures

Findings on visual photosensitivity in two phase 1/2 clinical trials of subretinal gene therapy with AGTC-401 and AGTC-402 for CNGB3 and CNGA3 achromatopsia

Leber Hereditary Optic Neuropathy Gene Therapy: Adverse Events and Visual Acuity Results of all Patient Groups

Interim Safety Results in Two Phase 1/2 Open-label, Dose-escalation Clinical Trials of Subretinal Gene Therapy with AGTC-401 (rAAV2tYF-PR1.7-hCNGB3) and AGTC-402 (rAAV2tYF-PR1.7-hCNGA3) in Subjects with Achromatopsia (ACHM)

The Relationship Between Stage of Leber's Hereditary Optic Neuropathy and Pattern Electroretinogram Latency

Progressive shortening of Steady-State Pattern ERG latency with increased LHON severity

Twelve-month Findings from Two Phase 1/2 Clinical Studies of Subretinal Gene Therapy Drugs for Achromatopsia

A Novel Method to Detect and Monitor Retinal Vasculitis Using Swept Source OCT Angiography

Preliminary results in 18 patients undergoing retinal gene therapy for X-linked retinitis pigmentosa with codon-optimized AAV8-RPGR

Gene Therapy for Leber Hereditary Optic NeuropathY An update of Where We Stand (Clinicaltrials.gov number: NCT02161380)

Prevalence of Retinal Gene Mutations in Patients Undergoing Evaluation for Autoimmune Retinopathy with Antiretinal Antibodies

Polymerase Chain Reaction for the Diagnosis of Chorioretinal Infections: Comparative Study of Testing in a Single Institution

Polymerase Chain Reaction in the Diagnosis of Toxoplasma gondii Chorioretinitis

OCT-Angiography in Vogt Koyanagi Harada Syndrome: A Comparative Cross Sectional Imaging Analysis

Pars plana vitrectomy for the treatment of uveitis

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Choroideremia Gene Therapy Phase II Clinical Trial: 6-Month Results

Neutralizing Antibodies Against Adeno-associated virus (AAV)2 Capsids in LHON Gene Therapy Clinical Trial Patients: An Update

Gene Therapy for LHON Suppresses Neurodegeneration

Feasibility of a Self-administered, Computer Guided, Visual Perception Training Software for the Argus II Retinal Prosthesis.

To View More...

You must be signed into an individual account to use this feature.